首页|RT-RAA联合CRISPR/Cas12a快速检测新型冠状病毒方法的建立与评价

RT-RAA联合CRISPR/Cas12a快速检测新型冠状病毒方法的建立与评价

扫码查看
目的 建立一种基于反转录酶-重组酶介导等温核酸扩增技术(RT-RAA)联合簇状规则间隔的短回文重复序列(CRISPR)/Cas12a系统的快速检测新型冠状病毒(SARS-CoV-2)的方法,并对其进行评价.方法 根据NCBI数据库中SARS-CoV-2的核衣壳(N)基因设计RT-RAA引物和CRISPR来源RNA(crRNA),优化检测体系中乙酸镁(MgAc)用量、RT-RAA反应温度和时间以及LbCas12a反应温度.以100~106 copies/μL重组质粒和其他呼吸道病原体分别评估该方法灵敏度和特异性.采用RT-RAA-CRISPR/Cas12a法和RT-PCR法对70份临床标本进行平行检测,比较两种方法的符合率.结果 优化后的RT-RAA-CRISPR/Cas12a检测方法可在37 ℃条件下50 min内完成SARS-CoV-2检测.荧光法检测灵敏度为10 copies/μL,侧流层析法为1 × 102 copies/μL.该方法能特异检测SARS-CoV-2,与其他呼吸道病原体无交叉反应.RT-RAA-CRISPR/Cas12a法检测70份临床标本的 结果与RT-PCR法完全一致,符合率为100%.结论 建立的RT-RAA-CRISPR/Cas12a法检测SARS-CoV-2快速、经济、灵敏度高、特异性强,无需昂贵仪器设备,可由经验不足的人员操作,为临床快速诊断和现场大规模筛查SARS-CoV-2提供了新的思路和方法.
Establishment and evaluation of RT-RAA combined with CRISPR/Cas12a for rapid detection of SARS-CoV-2
Objective To establish and evaluate a rapid detection method for SARS-CoV-2 based on reverse transcriptase-recombinase aided amplification(RT-RAA)combined with the clustered regularly interspaced short palindromic repeats(CRISPR)/Cas12a system.Methods RT-RAA primers and CRISPR-derived RNA(crRNA)were designed based on the nucleocapsid(N)gene of SARS-CoV-2 from NCBI database.The detection system was optimized with magnesium acetate(MgAc)concentration,RT-RAA reaction tempera-ture and time and LbCas12a reaction temperature.The sensitivity and specificity of the method were evaluated using recombinant plas-mids(100-106 copies/µL)and other respiratory pathogens.The RT-RAA-CRISPR/Cas12a method was compared with RT-PCR by tes-ting 70 clinical samples in parallel.Results The optimized RT-RAA-CRISPR/Cas12a assay could detect SARS-CoV-2 within 50 min at 37 ℃.The limit of detection was 10 copies/µL for the fluorescence-based method and 1×102 copies/μL for the lateral flow assay.The method specifically detected SARS-CoV-2 without cross-reactivity to other respiratory pathogens.The results of testing 70 clinical samples using RT-RAA-CRISPR/Cas12a showed agreement of 100%with those of RT-PCR.Conclusion The established RT-RAA-CRISPR/Cas12a assay for SARS-CoV-2 detection is rapid,cost-effective,highly sensitive and specific.It can be performed by less experienced personnel and no expensive equipment is required,thus it may provide a new approach for rapid clinical diagnosis and large-scale on-site screening of SARS-CoV-2.

SARS-CoV-2reverse transcriptase-recombinase aided amplificationCRISPR/Cas12alateral flow assayrapid detection

章太婵、车玉传、梁雪雁、韦华贵、范向平、黄承仕、林敏、陈江涛

展开 >

惠州市中心人民医院检验科,广东惠州 516008

汕头大学附属潮州市人民医院检验科,广东潮州 521011

右江民族医学院附属医院检验科,广西百色 533099

新型冠状病毒 重组酶介导等温扩增 CRISPR/Cas12a 侧流层析 快速检测

惠州市科技研发计划社会发展领域研发项目

210426104574869

2024

临床检验杂志
江苏省医学会

临床检验杂志

CSTPCD
影响因子:0.746
ISSN:1001-764X
年,卷(期):2024.42(4)
  • 17